Evidence map›Paper›PMID 40427779›Full record

ArticleInternational journal of environmental research and public health2025

PrEP Navigator Perceptions of the Implementation of Injectable PrEP on HIV Prevention in Tennessee.

Cristian J Chandler, David G Schlundt, Chloe Dagostino, Kemberlee R Bonnet, Ashley J Sellers, Latrice C Pichon, Leah R Alexander

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cristian J ChandlerDivision of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN 37203, USA.ORCID 0000-0003-1770-4357
David G SchlundtDepartment of Psychology, Vanderbilt University, Nashville, TN 37240, USA.ORCID 0000-0001-7069-9644
Chloe DagostinoDepartment of Psychology, Vanderbilt University, Nashville, TN 37240, USA.
Kemberlee R BonnetDepartment of Psychology, Vanderbilt University, Nashville, TN 37240, USA.ORCID 0000-0003-4046-3408
Ashley J SellersDepartment of Psychology, Vanderbilt University, Nashville, TN 37240, USA.ORCID 0009-0002-7453-696X
Latrice C PichonSchool of Public Health, University of Memphis, Memphis, TN 38152, USA.ORCID 0000-0002-2035-8267
Leah R AlexanderDepartment of Public Health Practice, Meharry Medical College, Nashville, TN 37208, USA.

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John Koethe · 2015 to 2026
$27.5M
NIH HHS P30 AI110527NIH HHS UL1 TR002243
6 · The paper itself

Abstract

Tennessee is in the southern region of the United States and has not yet fully benefitted from HIV pre-exposure prophylaxis (PrEP). Relatively little research has focused on pivotal roles of PrEP navigators. This study examined PrEP navigator perceptions of implementing long-acting injectable (LAI) PrEP in Tennessee. Semi-structured interviews with state-funded navigators were audio-recorded, transcribed, and systematically coded using a hierarchical system. Coded transcripts were aggregated, sorted, and analyzed using an iterative inductive/deductive qualitative approach. Using the Consolidated Framework for Implementation Research (CFIR), institutional, individual, and modifying factors to initiating and transitioning to LAI PrEP were identified. Most navigators initially had limited training and experience with LAI PrEP. Navigators reported systemic barriers associated with accessibility to LAI PrEP such as health insurance, pharmaceutical policies, and cost policies. While navigators noted the continued support of the state health department, strategies for circumventing individual and structural barriers are needed for universally implementing injectable PrEP.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdultFemaleHumansInjectionsMaleMiddle AgedTennesseeAnti-HIV AgentsCFIRHIVimplementationlong-acting injectablepre-exposure prophylaxisPrEPTennessee

Identifiers

PMID40427779
PMCPMC12110792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.